V lly inherited bleeding disorder caused by qualitative and/or quantitative deficiency of von Willebrand factor (vWF).' vWF has a central role in primary hemostasis, where it facilitates platelet-subendothelial binding. It also acts in plasma as a carrier of factor VIII. It is synthesized in vascular endothelial cells' and megakaryocytes,-' and is found in plasma and platelets as a series of multimeric glycoproteins ranging in molecular weight from 5 x IO5 to approximately 2 x lo7 daltons. Many types of vWD have been reported, with differential classification generally based on the multimeric profile seen in plasma and platelets.' In general, type I vWD consists of cases where reduced levels of vWF are accompanied by normal multimeric profiles. The many subtypes of type I1 vWD are characterized by abnormal multimeric profiles and loss of the highest molecular weight (HMW) forms. These H M W forms have been shown to possess the highest level of biologic a~t i v i t y .~ Type I11 vWD are severely affected with very low or undetectable levels of vWF in plasma and platelets. While types I and I1 are dominantly inherited, type I11 are recessive conditions, with affected individuals being either homozygotes or compound heterozygotes.
The vWF gene has been studied in some detail and is located on chromosome 12.5-'5 It has 52 exons and is approximately 180 kilobases (kb) in length.I6 The gene encodes a protein of 2,813 amino acids, consisting of a 22-amino acid signal peptide, a propeptide of 741 amino acids that is essential for multimerization and is cleaved before release into plasma, and a mature vWF subunit of 2,050 amino acids (250,000 daltons). Family studies in vWD have been recently improved after the identification of a t least 10 restriction fragment length polymorphisms (RFLP) within the vWF Studies have clearly shown their utility in tracking defective vWFgenes in affected kindred. 26.27 In this study we report the application of a polymorphic region of ATCT repeats (variable number tandem repeat; VNTR) within intron 40 of the vWF gene to gene tracking. This region was identified during studies on a severe homozygous vWD patient with a partial vWF gene deletion that included exon 42." It was a coincidental finding that we believe was not related to the patient's defective vWF gene.
The variable length of the VNTR region has been examined by polymerase chain reaction (PCR) amplification based on the method of Saiki et al,29 and has been used successfully in gene tracking in families with vWD and in prenatal diagnosis of a fetus at risk of severe type I11 vWD.
MATERIALS AND METHODS
Blood was obtained from vWD patients, their families, and normal controls after informed consent. Approval was obtained from the ethical review panel of the University Hospital of Wales for all studies reported here. Blood was anticoagulated 9:l in 3.8% trisodium citrate, and either analyzed directly or stored at -7OOC.
Preparation of DNA. DNA was prepared from whole blood according to the method of Kunkel et al." In later studies direct amplification of DNA from blood without prior extraction was performed. In this procedure, 200 pL of citrated whole blood was frozen at -2OoC, thawed, and placed at 95OC for 10 minutes. It was then centrifuged at 12,OOOg for 10 minutes and the supernatant carefully removed. This was diluted 1:lO in distilled water, and 2.5 pL was used directly in the PCR procedure.
DNA was also amplified directly from the chorionic villus sample (CVS) obtained for prenatal diagnosis. The pellet of villi was washed in 100 mmol/L NaCl, 10 mmol/L Tris-HC1 pH 8.0, 1 mmol/L EDTA, and resuspended in 50 pL of 100 mmol/L NaOH, 2 mol/L NaC1, and 0.5% sodium dodecyl sulfate. The pellet was disrupted by vortexing, and the suspension was boiled for 2 minutes and then centrifuged at 12,000gfor IO minutes. Supernatant, 2.5 pL was used directly for PCR amplification as described above.
In vWD family studies, a series of previously reported RFLPs were examined using Southern blotting procedures as previously described." Partial cDNA probes were prepared from a full-length vWF cDNA probe kindly supplied to us by Dr Dennis Lynch (Harvard Medical School, Boston, MA). The probes used were as reported in the original RFLP report^,^'-^^^^^ and detected RFLPs for restriction enzymes BglII, BamHI, XbaI, XbaI, and Sad, respectively.
To examine the variability of this region in further DNA samples, the PCRZ9 was used to amplify the VNTR region of the vWF gene. Primers were synthesized on an Applied Bio-Systems 38 1A oligonucleotide synthesizer (Warrington, UK) to DNA 5' and 3' to the VNTR region, such that 12 repeats would give a 123 base pair (bp) amplified fragment. Primer sequences used were: primer 1 : 5'-AGCTATATATCTATTTAT-CAT-3'; primer 2: The vWF.VNTR region of genomic DNA from individuals comprising the range of vWF.VNTR sizes was quantitatively amplified by a minor modification of the PCR procedure described above. DNA (50 mg) in 1X reaction buffer, containing 100 pmol/L dNTP and 0.9 pmol/L of primers 1 and 2 in a final volume of 100 pL, was denatured at 94OC for 5 minutes. TaqI polymerase (1 U) was then added at 48OC, and 30 cycles of PCR were performed as follows: polymerase extension at 72OC for 30 seconds, denaturation at 94OC for 30 seconds, and primer annealing at 48OC for 30 seconds.
The PCR products were electrophoresed on a 1.4% low-melting temperature agarose gel, and the product containing the vWF.VNTR was isolated and purified by established proced~res.'~ An aliquot of the isolated vWF.VNTR PCR product was then used as the substrate in a second PCR, identical to that described above with the exception that the primers were present in unequal quantities to generate single-stranded templates for sequencing (primer 1 :primer 2, 50:l). The products from this second PCR were purified by gel-filtration through a Sephadex-G5O column (1 mL) (Pharmacia, Milton Keynes, UK) equilibriated with sterile H,O, and the column eluent was used directly in the sequencing reactions.
Sequencing was performed using Sequenase (United States Biochemical Corporation, Cleveland, OH) according to the instructions of the manufacturer. However, the labeling reaction steps were omitted entirely because the PCR fragment to be sequenced was small. Instead, 10 pL of annealed primer-template was mixed with 0.1 mol/L DTT (1 pL), (cy-"P) dCTP (800 Ci/mmol) (0.5 pL), sterile H,O (2 pL), and diluted Sequenase (2 pL). Then 3.5 pL of the final mixture was added to 2.5 pL of each termination reaction mix, and the protocol continued as indicated by the manufacturer.
The sequencing reactions were electrophoresed on a vertical, nongradient denaturing acrylamide gel (6% acrylamide, 7 mol/L urea) in 0.5X TBE buffer at 2,000 V for approximately 2 hours. Sequencing gels were fixed with methano1:acetic acid:H,O (1:1:8, vol/vol) and dried down on a Bio-Rad model 443 gel drier (Watford, UK). Gels were then overlaid with x-ray film and exposed overnight at -8OOC. Sequences were read by eye.
All vWF.VNTR PCR fragments were sequenced at least twice from separate preparations, and vWF.VNTR PCR fragments of the same size in different individuals were sequenced for comparison.
Plasma from patients and relatives in vWD kindred were assayed for factor VI11 and vWF by standard procedures. Factor VI11 procoagulant activity (VIIIC) was determined by a 1-stage assay,)' and factor VI11 antigen (VIIIAg) and vWF antigen (vWFAg) by monoclonal antibody-based enzymelinked immunosorbent assay^.'^ vWF ristocetin cofactor activity was Fig 1. T h e precise size of each band seen was determined by direct DNA sequencing after PCR, the sequencing gel being shown in Fig 2. vWF.VNTR bands containing between 6 and 14 ATCT repeats have been identified with the exception, so far, of vWF.VNTR (9) . T h e overall population frequency of these bands in our local population (white, European) is summarized in Table 1. vWF.VNTR(12) and vWF.VNTR(7) were the most frequent, and a n overall heterzygosity rate of 75% was seen. These results were obtained by analysis of 53 unrelated individuals (106 chromosomes 12).
As well as the bands seen at 13 1 bp [vWF.VNTR ( 14) ] or lower in the P C R analysis gels, other larger bands are consistently seen, some of which appear to mirror the vWF.VNTR bands (see Fig I) . Detailed analysis of the DNA~quenccofvWFintron405'and 3'tothevWF.VNTR region showed that the DNA in this area is very repetitive.
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Computer analysis showed sequences that difTered from that of the primers used by only 2 or 3 bases. and it is thought that the extra bands are a mu11 of PCR amplification resulting from primer binding at these closely homologous sites.
When a vWFVNTR(7) PCR fragment was used as a probe in Southern blots of EmRI digested human DNA. t h m hybridiiation signals were obtained at relatively high wash stringencies (data not shown). Thus, at least two other loci homologous to or closely homologous to the vWF.VNTR region must exist in the human genome.
Mendelian inheritance of the vWF.VNTR bands was demonstrated in six three-generation families, and in no case was a band that was not present in the parents seen in an olTspring. In families with vWD the vWF.VNTR pattern was compared to gene tracking with reported RFLPs. In the family of M.R.. a patient with Severe type 111 vWD (Fig 3 and Table 2 . individual 1112). vWF.VNTR inheritance was compared with RFLPs detected by Bglll, Sod. BumHI, and Mol. and with phenotypic data. The phenotypic data sugg a t that the propositus 1112 was a compound heterozygote for two recessive forms of vWD.
Both parents (113.114) had factor Vlll levels significantly higher than those of vW F, an observation previously reported in carriers of vWD by others." This pattern was also seen in three further membersof the patient's family (12.II2.1111). vWF.VNTR result of the patient's parents confirmed the compound heterozygous nature of her disease. Prenatal diagnosis based on vWF.VNTR data was performed in family AS. (Fig 4. Table 3 ). The parents (I 1.12). who had been extensively studied. both appeared to be carriers of recessive vWD and were asymptomatic. Phenotypic results on l l were similar to those carriers identified in family M.R., with below-normal vWF levels and normal factor VIII. I2 also had a normal factor VI11 level (170 U/dL), but while vWFAg was normal (56 U/dL), the vWFRiCo level was reduced at 5 U/dL (in this family botrocetin cofactor levels, vWFBOCOP~ were also measured and were normal in both parents). Of the siblings, one (112) had severe type I11 vWD with undetectable vWF, while the other I13 had phenotypic data similar to that found in his mother. RFLP analysis was uninformative within this family (results not shown). However, vWF.VNTR analysis showed both parents to be heterozygous vWF.VNTR( 12)/ vWF.VNTR (7), as was the son I13 (Fig 4) . The severely affected daughter I12 was homozygous vWF.VNTR(7)/ vWF.VNTR (7) . CVS material was obtained by a transabdominal procedure during the 10th week of the mother's third pregnancy. vWF.VNTR analysis of this material showed a vWF.VNTR(~)/VWF.VNTR(~) homozygous pattern identical to that of the affected family member (Fig 4) . A diagnosis of severe vWD was made. Because the vWF.VNTR technique was novel the parents elected for confirmation by fetal blood sampling at 18 weeks (also performed at Kings College Hospital, London, UK). The diagnosis was confirmed with VIIIC = 1 U/dL, vWFAg = t l U/dL, and vWFRiCo = <1 U/dL, and an elective termination was performed.
DISCUSSION
Gene tracking of defective genes by RFLP analysis has become an important procedure in carrier detection and prenatal diagnosis, and has been used extensively in a variety of inherited single gene disorders, including hemophilia A and B and the thalassemias. Cases where the particular defect itself can be readily identified at the gene level allow for specific diagnosis. However, this is still generally unavailable in many diseases, including hemophilia A and vWD. RFLP analysis has relied on Southern blot procedures that can be time-consuming, and the majority involve diallelic polymorphisms, the maximum heterozygosity rate of which can only be 50%. PCR methods to amplify the polymorphic region and detection by either specific oligonucleotide probes or restriction enzyme analysis are being introduced in many laboratories to shorten assay times and increase through-put of samples. 39 VNTR regions have been identified in several genes, including the {'globin genes,"' the insulin gene:' and the Hras oncogene:* Recent report^^^.^^ have also demonstrated a tandemly repeated hypervariable loci in the 3' flanking region of the apolipoprotein / I gene. In procedures similar to those reported in our study, the investigators used PCR to identify up to 14 variable length alleles, some differing in length by only 32 bp. The identification of VNTR regions has also formed the basis of the DNA finger-printing procedures now used widely in forensic medi~ine.4~ Recently, frequently occurring VNTRs containing dinucleotide repeats (CpA or TpG) have also been recognized, and PCR has been used to demonstrate the polymorphic nature of these region^.^^.^' It is clear that VNTR regions of repeat sequence within a particular gene represent potentially important polymorphic markers, and their usefulness increases with the number of different length sequences observed. The eight-allelic vWF.VNTR region within the vWF gene reported here is such an example. Not only is it highly informative, but its detection by a combination of PCR amplification, rapid polyacrylamide gel electrophoresis, and direct amplification of DNA without prior extraction means that results can be obtained within 8 to 10 hours. In a situation where the specific gene defect of the vWF gene in vWD has only been reported in a few cases, vWF.VNTR gene tracking represents the most useful approach presently available for gene tracking, particularly when applied to prenatal diagnosis and carrier detection in the recessive forms of the disease.
